<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">30140154</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>09</Month>            <Day>17</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>09</Month>            <Day>17</Day>        </DateRevised>        <Article PubModel="Electronic-eCollection">            <Journal>                <ISSN IssnType="Electronic">1178-2013</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>13</Volume>                    <PubDate>                        <Year>2018</Year>                    </PubDate>                </JournalIssue>                <Title>International journal of nanomedicine</Title>                <ISOAbbreviation>Int J Nanomedicine</ISOAbbreviation>            </Journal>            <ArticleTitle>Mitochondria-targeted delivery of doxorubicin to enhance antitumor activity with HER-2 peptide-mediated multifunctional pH-sensitive DQAsomes.</ArticleTitle>            <Pagination>                <MedlinePgn>4209-4226</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.2147/IJN.S163858</ELocationID>            <Abstract>                <AbstractText Label="Introduction" NlmCategory="UNASSIGNED">Multidrug resistance (MDR) of breast cancer is the major challenge to successful chemotherapy while mitochondria-targeting therapy was a promising strategy to overcome MDR.</AbstractText>                <AbstractText Label="Materials and methods" NlmCategory="UNASSIGNED">In this study, HER-2 peptide-PEG<sub>2000</sub>-Schiff base-cholesterol (HPSC) derivate was synthesized successfully and incorporated it on the surface of the doxorubicin (DOX)-loaded dequalinium (DQA) chloride vesicle (HPS-DQAsomes) to treat drug-resistant breast cancer. Evaluations were performed using human breast cancer cell and DOX-resistant breast cancer cell lines (MCF-7 and MCF-7/ADR).</AbstractText>                <AbstractText Label="Results" NlmCategory="UNASSIGNED">The particle size of HPS-DQAsomes was ~110 nm with spherical shape. In vitro cytotoxicity assay indicated that HPS-DQAsomes could increase the cytotoxicity against MCF-7/ADR cell line. Cellular uptake and mitochondria-targeting assay demonstrated that HPS-DQAsomes could target delivering therapeutical agent to mitochondria and inducing mitochondria-driven apoptosis process. In vivo antitumor assay suggested that HPS-DQAsomes could reach favorable antitumor activity due to both tumor targetability and sub-organelles' targetability. Histological assay also indicated that HPS-DQAsomes showed a strong apoptosis-inducing effect. No obvious systematic toxicity of HPS-DQAsomes could be observed.</AbstractText>                <AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">In summary, multifunctional HPS-DQAsomes provide a novel and versatile approach for overcoming MDR via mitochondrial pathway in cancer treatment.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Shi</LastName>                    <ForeName>Menghao</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, People's Republic of China, raura3687ye@163.com.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Zhang</LastName>                    <ForeName>Jiulong</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, People's Republic of China, raura3687ye@163.com.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Li</LastName>                    <ForeName>Xiaowei</ForeName>                    <Initials>X</Initials>                    <AffiliationInfo>                        <Affiliation>School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, People's Republic of China, raura3687ye@163.com.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Pan</LastName>                    <ForeName>Shuang</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, People's Republic of China, raura3687ye@163.com.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Li</LastName>                    <ForeName>Jie</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Pharmacy, Mudanjiang Medical University, Mudanjiang, Heilongjiang 157011, People's Republic of China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Yang</LastName>                    <ForeName>Chunrong</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>College Pharmacy of Jiamusi University, Jiamusi, Heilongjiang 154007, People's Republic of China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Hu</LastName>                    <ForeName>Haiyang</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, People's Republic of China, raura3687ye@163.com.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Qiao</LastName>                    <ForeName>Mingxi</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, People's Republic of China, raura3687ye@163.com.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Chen</LastName>                    <ForeName>Dawei</ForeName>                    <Initials>D</Initials>                    <AffiliationInfo>                        <Affiliation>School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, People's Republic of China, raura3687ye@163.com.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Zhao</LastName>                    <ForeName>Xiuli</ForeName>                    <Initials>X</Initials>                    <AffiliationInfo>                        <Affiliation>School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, People's Republic of China, raura3687ye@163.com.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>07</Month>                <Day>18</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>New Zealand</Country>            <MedlineTA>Int J Nanomedicine</MedlineTA>            <NlmUniqueID>101263847</NlmUniqueID>            <ISSNLinking>1176-9114</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D008081">Liposomes</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D010455">Peptides</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D012545">Schiff Bases</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>30IQX730WE</RegistryNumber>                <NameOfSubstance UI="D011092">Polyethylene Glycols</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>80168379AG</RegistryNumber>                <NameOfSubstance UI="D004317">Doxorubicin</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>9007-43-6</RegistryNumber>                <NameOfSubstance UI="D045304">Cytochromes c</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>97C5T2UQ7J</RegistryNumber>                <NameOfSubstance UI="D002784">Cholesterol</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>E7QC7V26B8</RegistryNumber>                <NameOfSubstance UI="D003868">Dequalinium</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 2.7.10.1</RegistryNumber>                <NameOfSubstance UI="C508053">ERBB2 protein, human</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 2.7.10.1</RegistryNumber>                <NameOfSubstance UI="D018719">Receptor, ErbB-2</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Pharm Biopharm. 2018 Mar;124:104-115</RefSource>                <PMID Version="1">29305141</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Liposome Res. 2006;16(3):249-64</RefSource>                <PMID Version="1">16952879</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Control Release. 2003 Sep 19;92(1-2):189-97</RefSource>                <PMID Version="1">14499196</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Exp Med. 1995 Aug 1;182(2):367-77</RefSource>                <PMID Version="1">7629499</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Sci Rep. 2015 Nov 04;5:16125</RefSource>                <PMID Version="1">26530454</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pharm Res. 2013 Nov;30(11):2832-42</RefSource>                <PMID Version="1">23921486</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Cell Biol. 2000 Mar;2(3):E41-3</RefSource>                <PMID Version="1">10707095</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet. 2017 Mar 18;389(10074):1134-1150</RefSource>                <PMID Version="1">27865536</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mitochondrion. 2013 Sep;13(5):526-32</RefSource>                <PMID Version="1">23000575</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Control Release. 2017 Dec 10;267:223-231</RefSource>                <PMID Version="1">28917532</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Pharm Sci. 2013 Nov 20;50(3-4):420-8</RefSource>                <PMID Version="1">23981338</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Science. 1998 Aug 28;281(5381):1309-12</RefSource>                <PMID Version="1">9721092</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biomaterials. 2011 Aug;32(24):5673-87</RefSource>                <PMID Version="1">21550109</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Acta Biomater. 2018 Jan 15;66:310-324</RefSource>                <PMID Version="1">29129789</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Acta Biomater. 2014 May;10(5):2024-35</RefSource>                <PMID Version="1">24365705</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Exp Eye Res. 2013 Jan;106:47-54</RefSource>                <PMID Version="1">23116562</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mitochondrion. 2007 Feb-Apr;7(1-2):63-71</RefSource>                <PMID Version="1">17296332</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Food Chem Toxicol. 2017 May;103:223-232</RefSource>                <PMID Version="1">28315369</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Pharm. 2014 Aug 4;11(8):2640-9</RefSource>                <PMID Version="1">24811541</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Med Chem. 2017 Sep 29;138:273-292</RefSource>                <PMID Version="1">28675836</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pharmacol Res. 2017 Dec;126:97-108</RefSource>                <PMID Version="1">28501517</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Oncol Nurs. 2017 Aug;29:17-22</RefSource>                <PMID Version="1">28720261</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biomaterials. 2018 Feb;156:217-237</RefSource>                <PMID Version="1">29207323</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Control Release. 2016 Jul 28;234:68-78</RefSource>                <PMID Version="1">27164544</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pharmacol Res. 2017 Dec;126:2-30</RefSource>                <PMID Version="1">28760489</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biomaterials. 2015 Jun;52:126-39</RefSource>                <PMID Version="1">25818419</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Pharm. 2010 Dec 6;7(6):2194-206</RefSource>                <PMID Version="1">20973534</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Acta Biomater. 2017 Mar 1;50:381-395</RefSource>                <PMID Version="1">27956367</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biomaterials. 2013 May;34(14):3626-38</RefSource>                <PMID Version="1">23422592</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Control Release. 2001 Aug 10;75(3):401-8</RefSource>                <PMID Version="1">11489326</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Biosci Bioeng. 2013 Nov;116(5):634-7</RefSource>                <PMID Version="1">23735326</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biomaterials. 2015 Jan;37:405-14</RefSource>                <PMID Version="1">25453968</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biochem Pharmacol. 2017 May 15;132:29-37</RefSource>                <PMID Version="1">28242251</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pharmacol Ther. 2001 Oct;92(1):57-70</RefSource>                <PMID Version="1">11750036</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Nanomedicine. 2016 Aug 17;11:3951-67</RefSource>                <PMID Version="1">27574425</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Nanomedicine. 2008;3(3):311-21</RefSource>                <PMID Version="1">18990940</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mitochondrion. 2005 Oct;5(5):352-8</RefSource>                <PMID Version="1">16154389</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Toxicol Appl Pharmacol. 2016 Oct 15;309:2-14</RefSource>                <PMID Version="1">27554043</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nucl Med Biol. 2018 Feb;57:34-41</RefSource>                <PMID Version="1">29227814</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Exp Cell Res. 2006 Dec 10;312(20):4070-8</RefSource>                <PMID Version="1">17027968</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName>                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName>                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D002784" MajorTopicYN="N">Cholesterol</DescriptorName>                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D045304" MajorTopicYN="N">Cytochromes c</DescriptorName>                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D003868" MajorTopicYN="N">Dequalinium</DescriptorName>                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D004317" MajorTopicYN="N">Doxorubicin</DescriptorName>                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D016503" MajorTopicYN="Y">Drug Delivery Systems</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D065546" MajorTopicYN="N">Drug Liberation</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D019008" MajorTopicYN="N">Drug Resistance, Neoplasm</DescriptorName>                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D004705" MajorTopicYN="N">Endocytosis</DescriptorName>                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006863" MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008081" MajorTopicYN="N">Liposomes</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D061986" MajorTopicYN="N">MCF-7 Cells</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D053078" MajorTopicYN="N">Membrane Potential, Mitochondrial</DescriptorName>                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008819" MajorTopicYN="N">Mice, Nude</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName>                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D010316" MajorTopicYN="N">Particle Size</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName>                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011092" MajorTopicYN="N">Polyethylene Glycols</DescriptorName>                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D018719" MajorTopicYN="N">Receptor, ErbB-2</DescriptorName>                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D012545" MajorTopicYN="N">Schiff Bases</DescriptorName>                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D018675" MajorTopicYN="N">Toxicity Tests</DescriptorName>            </MeshHeading>        </MeshHeadingList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">DQAsomes</Keyword>            <Keyword MajorTopicYN="N">HER-2 peptide</Keyword>            <Keyword MajorTopicYN="N">mitochondrial target</Keyword>            <Keyword MajorTopicYN="N">pH responsive</Keyword>        </KeywordList>        <CoiStatement>Disclosure The authors report no conflicts of interest in this work.</CoiStatement>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>25</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>25</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30140154</ArticleId>            <ArticleId IdType="doi">10.2147/IJN.S163858</ArticleId>            <ArticleId IdType="pii">ijn-13-4209</ArticleId>            <ArticleId IdType="pmc">PMC6054761</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>